Skip to main content

Advertisement

SpringerLink
Log in

Predictive value of serum cystatin C, β2-microglobulin, and urinary liver-type fatty acid-binding protein on the development of contrast-induced nephropathy

  • Original Article
  • Published:
Cardiovascular Intervention and Therapeutics Aims and scope Submit manuscript

Abstract

Contrast-induced nephropathy (CIN) is associated with prolonged hospitalization and adverse clinical outcomes. Useful predictors of CIN are necessary to minimize the risk of developing CIN. The purpose of this study was to identify the useful predictors of CIN. We prospectively measured serum cystatin C (CysC) and β2-microglobulin (β2-MG), and urinary liver-type fatty acid-binding protein (L-FABP), β2-MG and N-acetyl-β-d-glucosaminidase (NAG) before and 1 day after percutaneous coronary intervention (PCI) in 96 patients with stable angina who underwent elective PCI. The frequency of CIN was 5% (5/96). Baseline levels of serum β2-MG (4.2 ± 2.6 vs. 2.2 ± 1.0 mg/L, p = 0.0007) and CysC (1.51 ± 0.52 vs. 1.11 ± 0.34 mg/L, p = 0.013) were significantly higher in the CIN group. Urinary β2-MG, NAG, and L-FABP levels became significantly elevated after PCI. Of these, the mean change of urinary L-FABP was significantly higher in the CIN group (25.2 ± 31.5 vs. 8.9 ± 16.3 ng/mL, p = 0.044). Univariate linear regression analyses showed that the change of urinary L-FABP correlated positively with the volume of contrast medium (r = 0.460, p < 0.0001). Receiver-operating characteristic analysis showed that baseline serum β2-MG exhibited 75% sensitivity and 80% specificity at a cut-off point of >2.8 mg/L, and baseline serum CysC exhibited 75% sensitivity and 73% at a cut-off point of >1.26 mg/L for predicting CIN. In conclusion, baseline serum β2-MG and CysC were useful predictors of CIN. The change of urinary L-FABP serves as an indicator of renal injury due to contrast medium and as an adjunct predictor of CIN.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. McCullough PA, Wolyn R, Rocher LL, Levin RN, O’Neill WW. Acute renal failure after coronary intervention: incidence, risk factors and relationship to mortality. Am J Med. 1997;103:368–75.

    Article  CAS  PubMed  Google Scholar 

  2. Rihal CS, Textor SC, Grill DE, Berger PB, Ting HH, Best PJ, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation. 2002;105:2259–64.

    Article  PubMed  Google Scholar 

  3. Tepel M, Zidek W. N-Acetylcysteine in nephrology: contrast nephropathy and beyond. Curr Opin Nephrol Hypertens. 2004;13:649–54.

    Article  CAS  PubMed  Google Scholar 

  4. Brezis M, Rosen S. Hypoxia of the renal medulla—its implications for disease. N Engl J Med. 1995;332:647–55.

    Article  CAS  PubMed  Google Scholar 

  5. Gruberg L, Mehran R, Dangas G, Mintz GS, Waksman R, Kent KM, et al. Acute renal failure requiring dialysis after percutaneous coronary interventions. Catheter Cardiovasc Interv. 2001;52:409–16.

    Article  CAS  PubMed  Google Scholar 

  6. Perrone RD, Madias NE, Levey AS. Serum creatinine as an index of renal function: new insights into old concepts. Clin Chem. 1992;38:1933–53.

    CAS  PubMed  Google Scholar 

  7. Haycock GB. Creatinine, body size and renal function. Pediatr Nephrol. 1989;3:22–4.

    Article  CAS  PubMed  Google Scholar 

  8. Coll E, Botey A, Alvarez L, Poch E, Quinto L, Saurina A, et al. Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment. Am J Kidney Dis. 2000;36:29–34.

    Article  CAS  PubMed  Google Scholar 

  9. Shlipak MG, Sarnak MJ, Katz R, Fried LF, Seliger SL, Newman AB, et al. Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med. 2005;352:2049–60.

    Article  CAS  PubMed  Google Scholar 

  10. Hamilton JA, Era S, Bhamidipati SP, Reed RG. Locations of the three primary binding sites for long-chain fatty acids on bovine serum albumin. Proc Natl Acad Sci USA. 1991;88:2051–4.

    Article  CAS  PubMed  Google Scholar 

  11. Veerkamp JH, Peeters RA, Maatman RG. Structural and functional features of different types of cytoplasmic fatty acid-binding proteins. Biochim Biophys Acta. 1991;1081:1–24.

    CAS  PubMed  Google Scholar 

  12. Kamijo A, Sugaya T, Hikawa A, Okada M, Okumura F, Yamanouchi M, et al. Urinary excretion of fatty acid-binding protein reflects stress overload on the proximal tubules. Am J Pathol. 2004;165:1243–55.

    CAS  PubMed  Google Scholar 

  13. Kamijo A, Kimura K, Sugaya T, Yamanouchi M, Hikawa A, Hirano N, et al. Urinary fatty acid-binding protein as a new clinical marker of the progression of chronic renal disease. J Lab Clin Med. 2004;143:23–30.

    Article  CAS  PubMed  Google Scholar 

  14. MacNeill BD, Harding SA, Bazari H, Patton KK, Colon-Hernadez P, DeJoseph D, et al. Prophylaxis of contrast-induced nephropathy in patients undergoing coronary angiography. Catheter Cardiovasc Interv. 2003;60:458–61.

    Article  PubMed  Google Scholar 

  15. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982–92.

    Article  CAS  PubMed  Google Scholar 

  16. Hayashi T, Nitta K, Hatano M, Nakauchi M, Nihei H. The serum cystatin C concentration measured by particle-enhanced immunonephelometry is well correlated with insulin clearance in patients with various types of glomerulonephritis. Nephron. 1999;82:90–2.

    Article  CAS  PubMed  Google Scholar 

  17. Nozue T, Michishita I, Iwaki T, Mizuguchi I, Miura M. Contrast medium volume to estimated glomerular filtration rate ratio as a predictor of contrast-induced nephropathy developing after elective percutaneous coronary intervention. J Cardiol. 2009;54:214–20.

    Article  PubMed  Google Scholar 

  18. Dharnidharka VR, Kwon C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis. 2002;40:221–6.

    Article  CAS  PubMed  Google Scholar 

  19. Kato K, Sato N, Yamamoto T, Iwasaki YK, Tanaka K, Mizuno K. Valuable markers for contrast-induced nephropathy in patients undergoing cardiac catheterization. Circ J. 2008;72:1499–505.

    Article  CAS  PubMed  Google Scholar 

  20. Artunc FH, Fischer IU, Risler T, Erley CM. Improved estimation of GFR by serum cystatin C in patients undergoing cardiac catheterization. Int J Cardiol. 2005;102:173–8.

    Article  CAS  PubMed  Google Scholar 

  21. Nakamura T, Sugaya T, Node K, Ueda Y, Koide H. Urinary excretion of liver-type fatty acid-binding protein in contrast medium-induced nephropathy. Am J Kidney Dis. 2006;47:439–44.

    Article  CAS  PubMed  Google Scholar 

  22. Nakamura T, Sugaya T, Koide H. Angiotensin II receptor antagonist reduces urinary liver-type fatty acid-binding protein levels in patients with diabetic nephropathy and chronic renal failure. Diabetologia. 2007;50:490–2.

    Article  CAS  PubMed  Google Scholar 

  23. Nakamura T, Sugaya T, Kawagoe Y, Suzuki T, Inoue T, Node K. Effect of pitavastatin on urinary liver-type fatty-acid-binding protein in patients with nondiabetic mild chronic kidney disease. Am J Nephron. 2006;26:82–6.

    Article  CAS  Google Scholar 

  24. Sheridan AM, Schwartz JH, Kroshian VM, Tercyak AM, Laraia J, Masino S, et al. Renal mouse proximal tubular cells are more susceptible than MDCK cells to chemical anoxia. Am J Physiol. 1993;265:F342–50.

    CAS  PubMed  Google Scholar 

  25. Kees-Folts D, Sadow JL, Schreiner GF. Tubular catabolism of albumin is associated with the release of an inflammatory lipid. Kidney Int. 1994;45:1697–709.

    Article  CAS  PubMed  Google Scholar 

  26. Kamijo A, Kimura K, Sugaya T, Yamanouchi M, Hase H, Kaneko T, et al. Urinary free fatty acids bound to albumin aggravate tubulointerstitial damage. Kidney Int. 2002;62:1628–37.

    Article  CAS  PubMed  Google Scholar 

  27. Tumlin J, Stacul F, Adam A, Becker CR, Davidson C, Lameire N, et al. CIN Consensus Working Panel pathophysiology of contrast-induced nephropathy. Am J Cardiol. 2006;98:14K–20K.

    Article  CAS  PubMed  Google Scholar 

  28. Kamijo-Ikemori A, Sugaya T, Kimura K. Urinary fatty acid binding protein in renal disease. Clin Chim Acta. 2006;374:1–7.

    Article  CAS  PubMed  Google Scholar 

  29. Solomon R, Werner C, Mann D, D’Elia J, Silva P. Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents. N Engl J Med. 1994;331:1416–20.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Cardiology, Department of Internal Medicine, Yokohama Sakae Kyosai Hospital, Federation of National Public Service Personnel Mutual Associations, 132 Katsura-cho, Sakae-ku, Yokohama, 247-8581, Japan

    Tsuyoshi Nozue, Ichiro Michishita & Ichiro Mizuguchi

Authors
  1. Tsuyoshi Nozue
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ichiro Michishita
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ichiro Mizuguchi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tsuyoshi Nozue.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nozue, T., Michishita, I. & Mizuguchi, I. Predictive value of serum cystatin C, β2-microglobulin, and urinary liver-type fatty acid-binding protein on the development of contrast-induced nephropathy. Cardiovasc Interv and Ther 25, 85–90 (2010). https://doi.org/10.1007/s12928-010-0014-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12928-010-0014-3

Keywords

Search

Navigation